IE000O5M6XO1
Ark Genomic Revolution Ucits ETF AccumUSD
etfLatest close · LSE
Past performance is not a reliable indicator of future results. Figures are shown after charges and, where indicated, after CPIH inflation.
Latest close · LSE9.06pas of 20/08/2026
Performance, after CPIH and after fees
5y nominal—Before inflation, before fees.
5y real (CPIH-adjusted)—After inflation. Spending power.
5y fee drag on £10k−£389OCF compounded across the five-year window.
Performance · 17 weekly observations
Growth of £10,000 · nominal£17,226▲ +72.3%
This fund
£16,686£14,660£12,634£10,608
27/07/202620/08/2026
Price source: LSE weekly closes via public market feeds · inflation adjustment: ONS CPIH.Past performance is not a reliable indicator of future results.
- Sharpe (5y)
- —
- Max drawdown (5y)
- —
- OCF
- 0.79%
- Volatility (annual)
- —
Sharpe is return ÷ volatility with a zero risk-free rate assumed (not excess-of-SONIA).
Holdings overlap · X-ray
See how much of this fund overlaps with the others you track — and where you are doubling up on the same companies.
Create a free accountFree with an account · information, not advice
Hold this fund via a UK platform
Platform list is alphabetical-by-type and not a recommendation. We may earn a referral fee if you open an account — this never affects our figures or rankings. Check platform fees and fund availability before investing.